Stock Scorecard



Stock Summary for Teva- Pharmaceutical Industries Ltd (TEVA) - $14.43 as of 3/27/2024 9:36:04 PM EST

Total Score

7 out of 29

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for TEVA

Positive earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for TEVA

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for TEVA

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2

Bonus Criteria for TEVA

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Latest News for for TEVA

Spotlight on Teva Pharmaceutical Indus: Analyzing the Surge in Options Activity - Teva Pharmaceutical Indus ( NYSE:TEVA ) 3/27/2024 7:30:00 PM
Jim Cramer Isn't 'Knocking' This Pharma Firm Anymore: 'As A Matter Of Fact, I'm Going In' - ARM Holdings ( NASDAQ:ARM ) , Comstock Resources ( NYSE:CRK ) 3/25/2024 1:05:00 PM
Alvotech Announces Increase in Number of Own Shares 3/22/2024 8:15:00 PM
Alvotech Announces Increase in Number of Own Shares 3/22/2024 8:15:00 PM
Pharmaceuticals Market In Germany size is set to grow by USD 21.44 bn from 2023-2027, Abbott Laboratories, AbbVie ... - PR Newswire 3/22/2024 4:18:00 PM
Senator Bernie Sanders Applauds GSK's Move To Cap Inhaler Costs At $35 Per Month - GSK ( NYSE:GSK ) 3/21/2024 11:17:00 AM
Alvotech Reports Financial Results for Full Year 2023 and Provides a Business Update 3/20/2024 8:15:00 PM
Alvotech Reports Financial Results for Full Year 2023 and Provides a Business Update 3/20/2024 8:15:00 PM
Global Contraceptive Drugs Market Size is Projected to Reach USD 28.96 billion by 2030, Growing at a CAGR of 7.3%: Straits Research - Agile Therapeutics ( NASDAQ:AGRX ) , GSK ( NYSE:GSK ) 3/12/2024 2:20:00 PM
iTeos Appoints Oncology Veteran Jill DeSimone to Its Board of Directors - ITeos Therapeutics ( NASDAQ:ITOS ) 3/6/2024 12:01:00 PM

Financial Details for TEVA

Company Overview

Ticker TEVA
Company Name Teva- Pharmaceutical Industries Ltd
Country USA
Description Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic drugs, specialty drugs, and biopharmaceuticals in North America, Europe, and internationally. The company is headquartered in Petach Tikva, Israel.
Sector Name LIFE SCIENCES
Industry Name PHARMACEUTICAL PREPARATIONS
Most Recent Quarter 12/31/2023
Next Earnings Date 5/1/2024

Stock Price History

Last Day Price 14.43
Last Day Price Updated 3/27/2024 9:36:04 PM EST
Last Day Volume 11,667,497
Average Daily Volume 8,985,348
52-Week High 14.23
52-Week Low 7.08
Last Price to 52 Week Low 103.81%

Valuation Measures

Trailing PE N/A
Industry PE 100.07
Sector PE 60.76
5-Year Average PE 3.73
Free Cash Flow Ratio 5.01
Industry Free Cash Flow Ratio 12.70
Sector Free Cash Flow Ratio 31.04
Current Ratio Most Recent Quarter 1.02
Total Cash Per Share 2.88
Book Value Per Share Most Recent Quarter 6.70
Price to Book Ratio 2.10
Industry Price to Book Ratio 5.57
Sector Price to Book Ratio 21.66
Price to Sales Ratio Twelve Trailing Months 1.00
Industry Price to Sales Ratio Twelve Trailing Months 13.94
Sector Price to Sales Ratio Twelve Trailing Months 8.77

Share Statistics

Total Shares Outstanding 1,120,990,000
Market Capitalization 16,175,885,700
Institutional Ownership N/A

Dividends

Ex-Dividend Date 11/27/2017
Last Dividend Amount 0.09
Current Dividend Amount 0.09
Dividend Aristocrat? False
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.00%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage -37.50%
3-Year Dividend Growth Rate Percentage -20.94%
5-Year Dividend Growth Rate Percentage -9.76%
All-Time Dividend Growth Rate Percentage 20.29%
Dividend Payout Ratio N/A

Income Statement

Quarterly Earnings Growth YOY 40.00%
Annual Earnings Growth 77.15%
Reported EPS 12 Trailing Months -0.50
Reported EPS Past Year 2.56
Reported EPS Prior Year 2.53
Net Income Twelve Trailing Months -592,000,000
Net Income Past Year -559,000,000
Net Income Prior Year -2,446,000,000
Quarterly Revenue Growth YOY 14.80%
5-Year Revenue Growth -4.07%

Balance Sheet

Total Cash Most Recent Quarter 3,226,000,000
Total Cash Past Year 3,226,000,000
Total Cash Prior Year 2,801,000,000
Net Cash Position Most Recent Quarter -45,046,000,000
Net Cash Position Past Year -45,046,000,000
Long Term Debt Past Year 48,272,000,000
Long Term Debt Prior Year 52,074,000,000
Total Debt Most Recent Quarter 48,272,000,000
Equity to Debt Ratio Past Year 0.13
Equity to Debt Ratio Most Recent Quarter 0.13
Total Stockholder Equity Past Year 7,506,000,000
Total Stockholder Equity Prior Year 7,804,000,000
Total Stockholder Equity Most Recent Quarter 7,506,000,000

Options

Put/Call Ratio 0.42
Has Options Options Chain
Liquidity Rating

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD 0.23
MACD Signal 0.30
20-Day Bollinger Lower Band 8.21
20-Day Bollinger Middle Band 11.40
20-Day Bollinger Upper Band 14.58
Beta 1.04
RSI 58.29
50-Day SMA 9.70
200-Day SMA 9.65

System

Modified 3/27/2024 8:25:56 AM EST